↓ Skip to main content

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

Overview of attention for article published in Frontiers in oncology, August 2022
Altmetric Badge

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma
Published in
Frontiers in oncology, August 2022
DOI 10.3389/fonc.2022.873830
Pubmed ID
Authors

Ke Su, Lu Guo, Kun He, Mingyue Rao, Jianwen Zhang, Xiaoli Yang, Weihong Huang, Tao Gu, Ke Xu, Yanlin Liu, Jing Wang, Jiali Chen, Zhenying Wu, Lanxin Hu, Hao Zeng, Hongyan Li, Jian Tong, Xueting Li, Yue Yang, Hanlin Liu, Yaoyang Xu, Zunyuan Tan, Xue Tang, Xunjie Feng, Siyu Chen, Binbin Yang, Hongping Jin, Lechuan Zhu, Bo Li, Yunwei Han

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 33%
Researcher 1 17%
Student > Master 1 17%
Unknown 2 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 33%
Neuroscience 1 17%
Unknown 3 50%